We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

LSE:0QIU

Novo Nordisk A/S (0QIU)

LSE • 0QIU • DK0062498333

272.70Last close

Market Closed

Trading Signals

ORTEX Data Highlights

As of Oct 28, 2026, ORTEX estimated 0% of free float sold short, 1.1 days to cover, cost to borrow 1.56%. Sign up for live short interest data.

Market Cap

180b USD | # 96 in GB

Volume

983.41k shares | 239.11m USD

Shares Outstanding

3.33b

Free Float Shares

94.64% | 3.16b

NYSE:NVO|

OTCPK:NONO.F|

DB:NOV|

DB:NOV0|

DB:NOV1|

DB:NOVA|

XTRA:NOV|

LSE:0TDD|

TSX:NOVO|

BOVESPA:N1VO34|

BASE:NVO|

BASE:NVOD|

WBAG:NNO2|

CPSE:NOVO B|

WSE:NVO|

NEOE:NVON

News

0QIU key data

Novo Nordisk A/S (LSE: 0QIU) has a market capitalization of $179.56B. Last close DKK 272.70 (as of 2026-11-12); 52-week range DKK 224.55 to DKK 409.90. ORTEX data as of 2026-10-28: short interest was 0.02% of free float, 1.1 days to cover and the average cost to borrow was 1.56%. Sign up for live short interest data.

0QIU news on ORTEX News
ORTEX News
ORTEX public data
ORTEX Charts
ORTEX API

© 2026 ORTEX Technologies Ltd.